Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating diaphyseal aclasis

A technology of backbone continuous syndrome and composition, which is applied in drug combination, bone disease, medical formula, etc., can solve problems such as lack of treatment options, shortening of long bones in limbs, and bone development disorders, so as to increase the burden on liver and kidney and relieve pain , the effect of alleviating clinical symptoms

Inactive Publication Date: 2015-04-08
董光宇
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no treatment plan for this disease, only when it affects the joint movement and compresses the tendon nerve, surgical removal is performed
However, since the diaphysis starts from the metaphysis, if it is not treated, it will often cause bone development disorders, often resulting in shortened or curved deformities of the long bones of the limbs, and short stature.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1, the weight ratio of raw materials: 20g of litchi core, 10g of Hovenia aurantii, 6g of safflower, 10g of Campanulaceae, 6g of comb sword, 10g of genus vine, 10g of kudzu root, 10g of aescin, 12g of loofah, Jiulixiang 2g, burnt malt 6g, burnt grain sprouts 20g.

[0030] The preparation method of Example 1 is: mix lychee core, hovenia ruthenium, water safflower seeds, platycodon grandiflorum, comb sword, terrazzo vine, kudzu root, aescin, loofah, jiulixiang, scorched malt and scorched grain buds, and add water to fry Boil, take the filtrate after 30 minutes, add water to the medicinal dregs and continue to decoct for 20 minutes, then take the filtrate, combine the two filtrates, divide into two parts, and apply heat to the affected area in the morning and evening.

Embodiment 2

[0031] Example 2, raw material drug weight ratio: 10 parts of lychee core, 6 parts of Hovenia trifoliata, 3 parts of water safflower, 6 parts of platycodon grandiflorum, 3 parts of comb sword, 6 parts of terrazzo, 6 parts of kudzu root, 1 branch of aescin 6 parts of flowers, 6 parts of loofah, 1 part of Jiulixiang, 3 parts of burnt malt, and 10 parts of burnt grain sprouts.

Embodiment 3

[0032] Example 3, the weight ratio of raw materials: 20 parts of litchi core, 10 parts of Hovenia ruthenium, 6 parts of safflower seed, 10 parts of platycodon grandiflorum, 6 parts of comb sword, 10 parts of terrazzo vine, 10 parts of kudzu root, 1 branch of aescin 10 parts of flowers, 10 parts of loofah, 2 parts of Jiulixiang, 6 parts of burnt malt, 20 parts of burnt grain sprouts.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating diaphyseal aclasis. The pharmaceutical composition is applied to the treatment of diaphyseal aclasis. The pharmaceutical composition is characterized by being prepared from the following raw pharmaceutical materials in proportioning ratio by weight: litchi chinensis Sonn., poncirus tuifoliata (L.) Raf., trachelospermum jasminoides (Lindl.) Lem., luffa cylindrica (L.) Roem., murraya jasminorage, polygonum orientale L., radix platycodi, radix puerariae, paris polyphylla Sm., diplazium lanceum (Thunb.) Presl, hordeum vulgare L. and setaria italica (L.) Beauv.. Proved by clinical trials, the pharmaceutical composition has the characteristics of good treatment effect and high safety in the adjuvant treatment of diaphyseal aclasis, so that the pharmaceutical composition is worthy of clinical application and popularization.

Description

technical field [0001] The invention relates to the field of orthopedics medicine, in particular to a pharmaceutical composition for treating diaphyseal syndrome. Background technique [0002] Diaphyseal aclasis is a developmental disorder of cartilage. Manifested as multiple exostoses and metaphyseal deformities, it is also known as metaphysialaclasis. The disease starts from chondrified bone and bone surrounded by periosteum, especially in the parts where the bone grows and falls, that is, the lower end of the femur, the proximal end of the tibia, and the distal end of the ulna. [0003] At present, there is no treatment plan for this disease, and surgical removal is only performed when it affects joint motion and compresses tendon nerves. However, since the diaphysis starts from the metaphysis, if it is not treated, it often causes skeletal development disorders, often resulting in shortened or curved deformities of the long bones of the limbs, and short stature. Cont...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8998A61P19/04
Inventor 董光宇王栋徐金林
Owner 董光宇
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products